| scholarly article | Q13442814 |
| P50 | author | Antonio Giordano | Q4776661 |
| Maria Grazia Cifone | Q56956369 | ||
| Francesca Lombardi | Q58236691 | ||
| Paola Palumbo | Q58236696 | ||
| Renato Galzio | Q53845167 | ||
| P2093 | author name string | Benedetta Cinque | |
| Annamaria Cimini | |||
| Cristina La Torre | |||
| Soheila Raysi Dehcordi | |||
| Gianfranca Miconi | |||
| P2860 | cites work | Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2 | Q24628857 |
| Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance | Q26765869 | ||
| Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome. | Q55460423 | ||
| Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. | Q55462710 | ||
| SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. | Q55465654 | ||
| Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction | Q71472376 | ||
| Reprogramming sertoli cells into pluripotent stem cells | Q87823195 | ||
| The dual role of iNOS in cancer | Q26786135 | ||
| Glioblastoma cancer stem cells: Biomarker and therapeutic advances | Q26859782 | ||
| Brain tumor stem cells: Molecular characteristics and their impact on therapy | Q27003138 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Immunity, Inflammation, and Cancer | Q27861048 | ||
| Targeting SOX2 as a Therapeutic Strategy in Glioblastoma | Q28079501 | ||
| The epidemiology of glioma in adults: a "state of the science" review | Q28387839 | ||
| Malignant gliomas in adults | Q29615708 | ||
| Immunobiological characterization of cancer stem cells isolated from glioblastoma patients | Q33740546 | ||
| Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation | Q33891224 | ||
| Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. | Q34630308 | ||
| Immunity, inflammation, and cancer: an eternal fight between good and evil | Q36106053 | ||
| Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells. | Q36255674 | ||
| Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy | Q36610286 | ||
| Molecular pathology of malignant gliomas | Q37014747 | ||
| Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. | Q37077666 | ||
| Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin | Q37570220 | ||
| Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma. | Q37660428 | ||
| Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting | Q38051894 | ||
| The sox family of transcription factors: versatile regulators of stem and progenitor cell fate | Q38071714 | ||
| Targeting role of glioma stem cells for glioblastoma multiforme. | Q38073851 | ||
| Role of microRNAs in mechanisms of glioblastoma resistance to radio- and chemotherapy | Q38099396 | ||
| iNOS: a potential therapeutic target for malignant glioma | Q38099450 | ||
| Cancer-related inflammation and treatment effectiveness | Q38256601 | ||
| Nitric oxide synthase in innate and adaptive immunity: an update. | Q38357835 | ||
| mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance. | Q38794065 | ||
| Investigating the role of tumour cell derived iNOS on tumour growth and vasculature in vivo using a tetracycline regulated expression system | Q38804591 | ||
| NOS Expression and NO Function in Glioma and Implications for Patient Therapies. | Q38842322 | ||
| Reactive oxygen species-dependent nitric oxide production in reciprocal interactions of glioma and microglial cells | Q39000567 | ||
| Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme. | Q39052091 | ||
| Immunological characterization of glioblastoma cells for immunotherapy | Q39141942 | ||
| Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells. | Q39146574 | ||
| Glioblastoma cell line-derived spheres in serum‑containing medium versus serum-free medium: a comparison of cancer stem cell properties | Q39290952 | ||
| Sox2, a key factor in the regulation of pluripotency and neural differentiation | Q41903725 | ||
| PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells. | Q48471999 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 25582-25598 | |
| P577 | publication date | 2017-03-10 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | NOS2 expression in glioma cell lines and glioma primary cell cultures: correlation with neurosphere generation and SOX-2 expression | |
| P478 | volume | 8 |
| Q103734026 | Characterization of adherent primary cell lines from fresh human glioblastoma tissue, defining glial fibrillary acidic protein as a reliable marker in establishment of glioblastoma cell culture |
| Q47867713 | Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar |
| Q58729699 | Involvement of NOS2 Activity on Human Glioma Cell Growth, Clonogenic Potential, and Neurosphere Generation |
| Q99630346 | MiR-330-3p functions as a tumor suppressor that regulates glioma cell proliferation and migration by targeting CELF1 |
| Q92940648 | NOS2 inhibitor 1400W Induces Autophagic Flux and Influences Extracellular Vesicle Profile in Human Glioblastoma U87MG Cell Line |
| Q91117895 | Prognostic significance of MEOX2 in gliomas |
| Q88619014 | Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma |
| Q92029579 | The cell-based approach in neurosurgery: ongoing trends and future perspectives |
Search more.